SEC Filing Analysis: Penumbra Inc (PEN)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer executed a small, pre-scheduled sale of common stock under a Rule 10b5-1 plan, indicating a routine transaction with negligible market impact.
• Market Impact: The transaction's value is insignificant relative to Penumbra's $10.60 billion market capitalization.

Company Information

Field	Value
Company	Penumbra Inc
Ticker Symbol	PEN
CIK	0001321732
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Roberts Johanna
CIK	0001751980
Title/Position	EVP, Gen. Counsel & Secretary
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-10
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	500
Price Per Share	$266.98 (Weighted Avg)
Total Value	$160,188.63
Shares Owned After	63,657
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$160,188.63
% of Market Cap	0.0015%
Shares Transacted	500
% of Shares Outstanding	0.0013%
Post-Transaction Ownership	63,657 shares (0.16% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $160k sale is trivial for a large-cap company valued at $10.60 billion.
• Ownership Concentration: The sale represents less than 1% of the insider's total holdings, and her remaining ownership is a small fraction (0.16%) of the total shares outstanding.
• Transaction Significance: The transaction is immaterial, representing a tiny percentage of both market cap and shares outstanding. Its execution under a Rule 10b5-1 plan confirms its routine nature.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is too small to influence the market. As a pre-scheduled sale under a 10b5-1 plan, it does not signal any new insider sentiment.

Volume & Sentiment

• Expected Volume Impact: None. The transaction size is a fraction of typical daily trading volume.
• Sentiment Indicator: Neutral. This is a routine, non-informational sale.

Additional Context

Special Circumstances

• The filing explicitly states in Footnote 1 that "The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan." This is a pre-arranged trading plan that allows insiders to sell shares at predetermined times to avoid accusations of trading on non-public information.